STRENSIQ

This brand name is authorized in Austria, Brazil, Canada, Estonia, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, United States

Active ingredients

The drug STRENSIQ contains one active pharmaceutical ingredient (API):

1 Asfotase alfa UNII Z633861EIM - ASFOTASE ALFA

Asfotase alfa, a human recombinant tissue-nonspecific alkaline phosphatase-Fc-deca-aspartate fusion protein with enzymatic activity, promotes mineralisation of the skeleton in patients with hypophosphatasia. Read about Asfotase alfa

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
STRENSIQ Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A16AB13		A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AB Enzymes
Discover more medicines within A16AB13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 565518120000201, 565518120000301, 565518120000401, 565518120000501
Country: CA	Health Products and Food Branch	Identifier(s): 02444615, 02444623, 02444631, 02444658
Country: EE	Ravimiamet	Identifier(s): 1696697, 1696709, 1696710, 1696721, 1696732, 1696743, 1696754, 1696765, 1696833, 1696844
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 035585, 071574, 183396, 586916
Country: FR	Base de données publique des médicaments	Identifier(s): 64450234, 69258437
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 309303, 309306, 309309, 309315
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7975, 8372, 8373, 8374, 8375
Country: IT	Agenzia del Farmaco	Identifier(s): 044478016, 044478028, 044478030, 044478042, 044478055, 044478067, 044478079, 044478081, 044478093, 044478105
Country: JP	医薬品医療機器総合機構	Identifier(s): 3959418A1021, 3959418A2028, 3959418A3024, 3959418A4020, 3959418A5027
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1078436, 1078437, 1078438, 1078439, 1078440, 1078441, 1078442, 1078443, 1078444, 1078445
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100354166, 100354172
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69029001, W69029002, W69029003, W69029004, W69029005, W69029006, W69029007, W69029008, W69030001, W69030002
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680131470020, 8680131470037, 8680131470044, 8680131470051
Country: US	FDA, National Drug Code	Identifier(s): 25682-010, 25682-013, 25682-016, 25682-019